These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1615428)

  • 1. The use of dysmorphology in birth defects epidemiology.
    Friedman JM
    Teratology; 1992 Feb; 45(2):187-93. PubMed ID: 1615428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of associations between birth defects and suspected human teratogens.
    Khoury MJ; James LM; Lynberg MC
    Am J Med Genet; 1991 Sep; 40(4):500-5. PubMed ID: 1746618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is a human teratogen: clinical and epidemiological criteria.
    Bertollini R; Pagano M; Mastroiacovo P
    Ann Ist Super Sanita; 1993; 29(1):97-104. PubMed ID: 8129277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big risks in small groups: The difference between epidemiology and counselling.
    Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2009 Aug; 85(8):720-4. PubMed ID: 19572407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between dysmorphology and epidemiology: methodologic issues of lumping and splitting.
    Khoury MJ; Moore CA; James LM; Cordero JF
    Teratology; 1992 Feb; 45(2):133-8. PubMed ID: 1615423
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical-epidemiologic assessment of pattern of birth defects associated with human teratogens: application to diabetic embryopathy.
    Khoury MJ; Becerra JE; Cordero JF; Erickson JD
    Pediatrics; 1989 Oct; 84(4):658-65. PubMed ID: 2674881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal pesticide exposure from multiple sources and selected congenital anomalies.
    Shaw GM; Wasserman CR; O'Malley CD; Nelson V; Jackson RJ
    Epidemiology; 1999 Jan; 10(1):60-6. PubMed ID: 9888281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of minor anomalies: II. Use in cohort studies to identify teratogens.
    Holmes LB; Kleiner BC; Leppig KA; Cann CI; Muñoz A; Polk BF
    Teratology; 1987 Dec; 36(3):291-7. PubMed ID: 3424217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of seasonal variation of birth defects in Atlanta.
    Siffel C; Alverson CJ; Correa A
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):655-62. PubMed ID: 16240376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital abnormalities of 88 children born to mothers who attempted suicide with phenobarbital during pregnany: the use of a disaster epidemiological model for the evaluation of drug teratogenicity.
    Timmermann G; Acs N; Bánhidy F; Czeizel AE
    Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):815-25. PubMed ID: 19551756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of DNA sample collection into a multi-site birth defects case-control study.
    Rasmussen SA; Lammer EJ; Shaw GM; Finnell RH; McGehee RE; Gallagher M; Romitti PA; Murray JC;
    Teratology; 2002 Oct; 66(4):177-84. PubMed ID: 12353214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological analysis of the association between two congenital anomalies in the same child: a method for adjusting nonspecific clustering.
    Prieto L; Martínez-Frías ML
    Am J Med Genet; 1996 Mar; 62(1):61-7. PubMed ID: 8779328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation of recurring weak associations obtained from epidemiologic studies of suspected human teratogens.
    Khoury MJ; James LM; Flanders WD; Erickson JD
    Teratology; 1992 Jul; 46(1):69-77. PubMed ID: 1641813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996.
    Czeizel AE; Rockenbauer M; Siffel C; Varga E
    Teratology; 2001 May; 63(5):176-85. PubMed ID: 11320528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of phenytoin, phenobarbital, or diazepam during pregnancy and risk of congenital abnormalities: a case-time-control study.
    Kjaer D; Horvath-Puhó E; Christensen J; Vestergaard M; Czeizel AE; Sørensen HT; Olsen J
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):181-8. PubMed ID: 16941718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based case-control study of oral ketoconazole treatment for birth outcomes.
    Kazy Z; Puhó E; Czeizel AE
    Congenit Anom (Kyoto); 2005 Mar; 45(1):5-8. PubMed ID: 15737124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal panic disorder and congenital abnormalities: a population-based case-control study.
    Acs N; Bánhidy F; Horváth-Puhó E; Czeizel AE
    Birth Defects Res A Clin Mol Teratol; 2006 Apr; 76(4):253-61. PubMed ID: 16583439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic methods in the search for causes of human birth defects.
    Ferencz C; Loffredo C; Wilson PD
    Teratology; 2000 Apr; 61(4):243-5. PubMed ID: 10716741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.